Filter
1172
Text search:
hospital
pharmacy
Featured
126
405
Language
Document type
630
203
197
66
29
20
11
8
3
2
2
1
Countries / Regions
66
58
51
45
44
36
35
34
33
32
30
27
24
24
20
18
17
17
15
14
13
13
12
11
10
10
9
8
8
7
7
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
656
56
48
42
34
26
13
1
Toolboxes
132
125
55
44
43
31
30
25
20
19
13
12
11
11
10
8
7
7
5
5
4
3
3
2
Transforming Health: Accelerating attainment of Health Goals | THE SECOND MEDIUM TERM PLAN FOR HEALTH
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for
...
SITUATION ANALYSIS AND RECOMMENDATIONS
DHS Further Analysis Reports No. 98
Yemen remains the site of one of the world’s largest humanitarian crises. A staggering 23.4 million people — 73 per cent of the population — require some form of humanitarian assistance in 2022, the result of seven years of escalating conflict.
Millions have been uprooted from their homes,
...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Final report 2016
